Results from assessing LS and non-LS-associated variants for susceptibility of CD4+ and CD8+ T-cells and of CD4/CD8 ratio in both healthy and diseased test groups provided considerable evidence for the plausibility of pleiotropy between susceptibility to sarcoidosis and T-cell levels. The gene discussed is CD4; the disease is sarcoidosis.